Pharming (PHAR) Return on Invested Capital (2021 - 2026)
Pharming's (PHAR) quarterly Return on Invested Capital came in at 0.0% in Q2 2026, up 125918.0% YoY from N/an in Q2 2025, and down 42.98% on a QoQ basis from 0.0% in Q1 2026.
Pharming (PHAR) Return on Invested Capital (2021 - 2026) Analysis & Trends
Pharming (PHAR) has 6 years of Return on Invested Capital data on file, last reported at 0.0% in Q2 2026.
- Quarterly Return on Invested Capital rose 125918.0% year-over-year to 0.0% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.0% (up 125918.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
- Return on Invested Capital fell to 0.0% in Q2 2026, from 0.0% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 234.84% in Q3 2024 to a low of 8903.83% in Q3 2025.
- A 5-year average of 712.1% and a median of 0.0% in 2022 frame the typical range for Return on Invested Capital.
- Annual changes were most pronounced in 2025 — Return on Invested Capital slumped 913866 bps — and 2026, when it surged 144489 bps.
- Tracing PHAR's Return on Invested Capital over 5 years: stood at 0.0% in 2022, then plunged by 125 bps to 0.0% in 2023, then sank by 295670099 bps to 1444.83% in 2024, then soared by 100 bps to 0.0% in 2025, then slumped by 60 bps to 0.0% in 2026.
- The last three Return on Invested Capital figures came in at 0.0% (Q2 2026), 0.0% (Q1 2026), and 0.0% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.05% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.35% |
| 10 | Pharming | 824.47 Mn | 666.19 Mn | 141.47 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | -8,903.83% |
| Jun 30, 2025 | -1,259.18% |
| Mar 31, 2025 | -1,444.89% |
| Dec 31, 2024 | -1,444.83% |
| Sep 30, 2024 | 234.84% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |